Drug
Telcagepant clinical trials
Also written MK-0974.
Includes 2 studies of Telcagepant potassium.
- studies test it
- 14
- open now
- 0
- in phase 3
- 6
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
14 studies that test it; most in 2008 (7)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 7 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 4
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 0
Often tested with
Tested in the same studies.
2-(8-(3,5-difluorophenyl)-6,8-dimethyl-10-oxo-6,9-diazaspiro(4.5)decan-9-yl)-N-(2'-oxospiro(1,3-dihydroindene-2,3'-1H-pyrrolo(2,3-b)pyridine)-5-yl)acetamide (1) · Ibuprofen (1)
Studies
Open first, then newest update. How each study uses telcagepant is read from its arms, and is right about nine times in ten.
Testing it · 14
- Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)CompletedPhase 1Merck Sharp & Dohme LLCNCT01315847Written as telcagepant
- Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)CompletedPhase 2/3Merck Sharp & Dohme LLCNCT01125774Written as Telcagepant
- A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)CompletedPhase 2Merck Sharp & Dohme LLCNCT00758836Written as telcagepant
- Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)CompletedPhase 3Merck Sharp & Dohme LLCNCT00662818Written as Telcagepant
- Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)CompletedPhase 3Merck Sharp & Dohme LLCNCT00483704Written as Telcagepant 140 mg
- A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)CompletedPhase 1Merck Sharp & Dohme LLCNCT01294709Written as telcagepant
- MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)TerminatedPhase 2Merck Sharp & Dohme LLCNCT00797667Written as Telcagepant 140 mg
- Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)CompletedPhase 3Merck Sharp & Dohme LLCNCT00442936Written as Telcagepant potassium 150 mg
- Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)CompletedPhase 3Merck Sharp & Dohme LLCNCT00443209Written as Telcagepant 300 mg soft gel capsules
- A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)CompletedPhase 2Merck Sharp & Dohme LLCNCT00246337Written as MK0974
- Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT01209741Written as telcagepant potassium
- Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042)CompletedPhase 1Merck Sharp & Dohme LLCNCT00966030Written as MK0974 tablet
- Bioequivalence of Two Tablet Forms of MK0974 (0974-045)CompletedPhase 1Merck Sharp & Dohme LLCNCT00965887Written as MK0974 Ethanolate formulation
- Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016)CompletedPhase 3Merck Sharp & Dohme LLCNCT00432237Written as MK0974 50 mg
Given in every arm · 1 — telcagepant is usual care beside what is tested
Codes
What other systems call telcagepant · ClinicalTrials.gg INT005205
- MeSH (NLM) C525458telcagepantOne source NLM
- UNII (FDA) D42O649ALLTELCAGEPANTConfirmed FDA, NLM, Wikidata
- Wikidata Q5675567telcagepantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152545TelcagepantOne source FDA
- DrugBank DB12228One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C525458 | telcagepant | One source NLM |
| UNII (FDA) | D42O649ALL | TELCAGEPANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5675567 | telcagepant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152545 | Telcagepant | One source FDA |
| DrugBank | DB12228 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.